With information from the latest evidence-based studies, participants should be able to:

• Describe the effects of ezetimibe plus simvastatin on atherosclerotic progression in patients with familial hypercholesterolemia 
• Recognize the association between lipoprotein(a) levels and future coronary heart disease (CHD) risk
• Delineate the relationships of plasma HDL cholesterol levels, HDL particle size, and apolipoprotein A-I with CHD risk

Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)

With information from the latest evidence-based studies, participants should be able to: 

• Describe the effects of different dyslipidemia phenotypes from childhood to adulthood and their interaction with nonlipid risk factors on markers of subclinical atherosclerosis
• Compare the usefulness of the triglyceride/high-density lipoprotein (HDL) ratio versus the total cholesterol/HDL ratio for predicting insulin resistance and cardiometabolic risk
• Access the efficacy and safety of single-pill amlodipine/atorvastatin therapy for the simultaneous treatment of hypertension and dyslipidemia in African American patients with risk of cardiovascular disease

With information from the latest evidence-based studies, participants should be able to:

• Outline the efficacy of statin therapy on the reduction in major vascular events in patients with diabetes 
• Describe the role of extreme lipoprotein(a) levels in the prediction of risk of myocardial infarction in the general population 
• Access the impact of triglyceride levels on coronary heart disease risk after an acute coronary syndrome

Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)